Research

The MCT8 Research Foundation supports selected, promising research projects that aim to explore and treat the disease itself, as well as the effects of the MCT8 gene mutation.
Priority will be given to projects to research and cure the severe form of AHDS, which affects about 95% of patients. The focus is on in vivo research for the discovery of a cure and better treatment for patients.

Supported projects may include new or existing projects in the fields of genetic research, chaperone treatment, administration of TRIAC or T3 delivery, e.g. using modified viruses. In addition, projects on stem cell activation in the brain or other approaches to CNS assembly and repair can be subsidized for AHDS disease.